Centrient Pharmaceuticals

Antibiotics are foundational to modern medicine—essential in treatments from newborn infections to lifesaving surgeries and cancer care. Yet, today, their availability is under threat due to antimicrobial resistance (AMR) and an increasingly fragile global supply chain. Our CEO, Rex Clements, recently addressed these pressing issues, highlighting how Centrient is working to secure reliable, sustainable access to life-saving antibiotics for patients worldwide. Read his article to discover why safeguarding these foundational medicines is essential for the future of healthcare—and how Centrient is leading the way. #Antibiotics #Healthcare #Sustainability

Happy Diwali! As we celebrate the Festival of Lights, we extend our warmest wishes to you and your families. May this Diwali bring joy, prosperity, and success to all, no matter where you are celebrating. Wishing you a Diwali filled with memorable moments, beautiful experiences, and abundant blessings. Stay safe and enjoy the festivities! 

We love this haunting illustration, just in time for Halloween. It’s a great guide to how we can curb AMR – and help tackle one of the scariest issues facing humanity today https://lnkd.in/eyMvdHzj

Get ready to be inspired! In this exciting interview, Jorge Gil-Martinez, Centrient’s Chief Scientific Officer, unveils the dynamic role of our Innovation Lab in Barcelona. This cutting-edge hub is dedicated to revolutionizing the sustainable manufacturing of foundational medicines. By harnessing the power of biotechnology and nature, the lab is set to spark innovation, drive growth, and expand Centrient’s portfolio. Now open in Almirall, the Innovation Lab is a beacon for open innovation, inviting collaborations with partners and attracting top talent from the vibrant Barcelona area. Its mission? To create an open innovation ecosystem and develop our own sustainable manufacturing processes that resonate with Centrient’s global mission to improve lives worldwide. Join us as we explore how this lab is not just a place, but a movement towards a healthier, more sustainable future! #Innovation #SustainableManufacturing

Did you know that, by making antibiotics and antifungals available in different dosage forms, we can help curb antimicrobial resistance (AMR)?   That’s because patients are more likely to adhere to treatment when they have access to medicine in their preferred dosage form. For example, many children struggle to swallow a pill whole and find it much easier to take their medicine in liquid form. By finishing their entire prescribed course of antibiotics or antifungals, patients can prevent pathogens from taking the opportunity to develop resistance.   At Centrient, not only are we a business-to-business supplier of antibiotic and antifungal ingredients, but we also manufacture finished dosage forms (FDFs) ranging from hard capsules to powders for oral suspension. Our range of FDFs help patients fight infections while also fighting AMR.

We are excited to announce the official opening of Centrient’s Innovation Laboratory at Almirall’s R&D centre in Sant Feliu de Llobregat, Barcelona! This lab is a crucial step for Centrient as it will drive our efforts in product diversification and the continued development of our sustainable manufacturing processes. By fostering collaboration with researchers from biotech companies, start-ups, universities, and other scientific institutions, we aim to create a hub for open innovation that will enhance our contributions to the global pharmaceutical value chain. Our CEO, Rex Clements, Chief Scientific Officer, Jorge Gil-Martinez, and Head of I&TD laboratories, Maria Duran, PhD, took part in the ribbon-cutting ceremony, marking this significant milestone. This new facility will be the focal point for our product and process innovation, helping us to diversify our portfolio and advance our biotechnology capabilities. For more information, read more in our press release here: https://lnkd.in/e3dv9si6

PSA: Don’t forget about fungi!   When we talk about antimicrobial resistance (AMR), it is bacteria – and antibiotics – that usually get the most attention. But the ‘A’ in AMR also encompasses other microbes, including fungi, that are often overlooked.   Now, drug-resistant fungal infections are on the rise as fungi evolve to resist the antifungal medications at our disposal. That’s a dangerous situation for us all.   Fungi are something we think about a lot at Centrient, as we are a global market leader in an antifungal – nystatin – that is classed as “essential” by the World Health Organization. Nystatin is used to treat candida infections, which affect up to one billion people each year. These fungal infections cause serious, even deadly, health problems in patients around the world.   To preserve the effectiveness of nystatin and other essential antifungals, let’s make sure fungi are part of the AMR conversation!

In the next quarter-century, three people per minute – on average – are expected to die from bacterial antimicrobial resistance (AMR).   That’s according to a new analysis carried out by the Global Research on Antimicrobial Resistance (GRAM) Project and published in The Lancet. This underscores the urgency of taking action to curb AMR and ensure antibiotics remain as effective as possible, for as long as possible. Read more ⬇️ https://lnkd.in/eZPKZhG6  

We are proud to announce that Centrient has become one of the first pharmaceutical companies to successfully pass the AMR Surveillance Audit conducted by BSI at our Santa Perpetua manufacturing site! As a key contributor to the development of the BSI and AMR Industry Alliance certification scheme, this audit assessed our operations to ensure they fully align with the rigorous AMR IA Antibiotic Manufacturing Standard and to assess the robustness of the certification process itself. Our commitment to sustainable and responsible manufacturing practices was validated as the manufacture and packaging of our APIs were found to fully conform with the standard. This is a critical step forward in our ongoing fight against antimicrobial resistance (AMR), and it highlights Centrient's dedication to leading the way in responsible antibiotic production. At Centrient, we believe in taking proactive steps to protect global health, and we’re proud to be at the forefront of this initiative. #AMR

Centrient recently recognized both World Inclusion Day and World Mental Health Day on October 10, reflecting our core value of Caring. At Centrient, we believe that inclusivity and mental well-being are essential for a supportive workplace. By fostering an environment where everyone feels valued and supported, we help our people thrive. Let’s continue to prioritize mental health and inclusivity every day. Don’t miss the insightful article from our Head of Talent Management and Organizational Development, Neha Singh, on these important causes and how we celebrate them at Centrient. #Caring #Centrient #WorldMentalHealthDay #WorldInclusionDay